1. Home
  2. MSBI vs RGNX Comparison

MSBI vs RGNX Comparison

Compare MSBI & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Midland States Bancorp Inc.

MSBI

Midland States Bancorp Inc.

HOLD

Current Price

$33.33

Market Cap

700.0M

Sector

Finance

ML Signal

HOLD

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

HOLD

Current Price

$8.54

Market Cap

793.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MSBI
RGNX
Founded
1881
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
700.0M
793.5M
IPO Year
2011
2015

Fundamental Metrics

Financial Performance
Metric
MSBI
RGNX
Price
$33.33
$8.54
Analyst Decision
Hold
Strong Buy
Analyst Count
3
8
Target Price
$24.33
$28.75
AVG Volume (30 Days)
114.7K
1.2M
Earning Date
04-23-2026
05-05-2026
Dividend Yield
5.00%
N/A
EPS Growth
N/A
18.08
EPS
1.56
N/A
Revenue
N/A
$10,393,000.00
Revenue This Year
$18.41
$51.21
Revenue Next Year
$2.07
$19.08
P/E Ratio
$21.08
N/A
Revenue Growth
N/A
126.48
52 Week Low
$14.24
$5.46
52 Week High
$35.10
$16.19

Technical Indicators

Market Signals
Indicator
MSBI
RGNX
Relative Strength Index (RSI) 53.14 38.76
Support Level $33.04 $7.92
Resistance Level $35.10 $11.17
Average True Range (ATR) 0.75 0.56
MACD -0.04 -0.11
Stochastic Oscillator 61.69 22.57

Price Performance

Historical Comparison
MSBI
RGNX

About MSBI Midland States Bancorp Inc.

Midland States Bancorp Inc is a diversified financial holding company. The company provides a full range of commercial and consumer banking products and services, business equipment financing, merchant credit card services, trust and investment management, and insurance and financial planning services. The Banking segment, which generates the majority of the revenue, provides financial products and services to consumers and businesses, including commercial, commercial real estate, mortgage, and other consumer loan products; commercial equipment financing, etc. The Wealth Management segment consists of trust and fiduciary services, brokerage, and retirement planning services. The Corporate segment includes the holding company's financing and investment activities, administrative expenses.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

Share on Social Networks: